Position in KRYS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$3,108,106
+$153,325 QoQ
Shares Held
12,032
+0.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 99.22706117021278.ToString("F0")%
Shared 0.ToString("F0")%
None 0.772938829787234.ToString("F0")%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Torray Investment Partners LLC holds $54,354,232 across 8 Biotechnology names. KRYS ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
645,425 | $30,961,037 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,386 | $6,870,464 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
78,170 | $4,415,823 | |
| 4 | KRYS |
Krystal Biotech, Inc.
This page
|
12,032 | $3,108,106 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
14,774 | $2,497,101 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
38,179 | $2,467,508 | |
| 7 | SNDX |
Syndax Pharmaceuticals Inc
|
104,868 | $2,449,716 | |
| 8 | VSTM |
Verastem, Inc.
|
298,958 | $1,584,477 |
All Filings in KRYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,108,106 | 12,032 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,954,781 | 11,985 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,100,883 | 11,901 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,590,962 | 11,574 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||